- ICH GCP
- Yhdysvaltain kliinisten tutkimusten rekisteri
- Kliininen tutkimus NCT06372860
DPP:n toteutettavuustutkimus imetyksestä - eMOMS 2.0
Diabetesehkäisyohjelman toteutettavuustutkimus imetyksestä – äidin aikataulun sähköinen seuranta 2.0
The purpose of this study is to investigate the impact of a comprehensive intervention that combines breastfeeding support with a diabetes prevention-based program (DPP) on postpartum weight retention and lactation duration among women with pre-pregnancy overweight or obesity. This intervention, named eMOMS, is delivered by a certified health coach via a mobile health (mHealth) application.
Tutkimuksen yleiskatsaus
Tila
Yksityiskohtainen kuvaus
This study is a randomized controlled trial designed to determine the feasibility and efficacy of a combined breastfeeding, diabetes prevention-based program (DPP) in a cohort of overweight or obese women to be followed during pregnancy through 3 months postpartum. The trial will have two study arms: DPP + breastfeeding (Tx1) and Usual Care (Tx2).
Aim 1: Measure weight loss and duration of lactation through 3 months postpartum among target population. To accomplish this, we will measure pre-pregnancy weight, weight at study entry, weight immediately prior to and after delivery, and weight at specific postpartum time points. Lactation and infant feeding practices will be measured at similar postpartum time points. Aim 2: Quantify interest in use of the DPP-lactation mobile health (mHealth) application among target population. To accomplish this, we will: (1) measure research engagement including rates of screening and recruitment among users, especially rural and racially/ethnically diverse women; and (2) evaluate intervention uptake, delivery, and adherence via tracking/measuring use of the mHealth app.
Opintotyyppi
Ilmoittautuminen (Todellinen)
Vaihe
- Ei sovellettavissa
Yhteystiedot ja paikat
Opiskelupaikat
-
-
Kansas
-
Wichita, Kansas, Yhdysvallat, 67218
- Via Christi Maternal Fetal Medicine Clinic
-
-
Osallistumiskriteerit
Kelpoisuusvaatimukset
Opintokelpoiset iät
Hyväksyy terveitä vapaaehtoisia
Sukupuolet, jotka voivat opiskella
Kuvaus
Inclusion Criteria:
- Pregnant
- In second trimester or early third trimester
- BMI >/= 25 and < 35
- At least 18 years old or older
- Able to read and understand English
- Able to learn and use a video platform
Exclusion Criteria:
- Complications related to pregnancy that require emergency care
- Thyroid disease
- Multiple gestation
- Substance abuse within last 3 years
- Assisted reproductive technology (ART)-related pregnancy
- Current smoker
- Prior bariatric surgery
- In weight-loss program within 3 months of conception
- BMI >/= 35
- Unable to attend intervention/ follow-up visits
- Unwilling to self-monitor data collection
- Unable to complete intervention
- Presence of any condition that limits walking
- Presence of any condition that limits following diet recommendations
- Pregnancies complicated with fetuses diagnosed with lethal malformations/conditions
Opintosuunnitelma
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
- Ensisijainen käyttötarkoitus: Hoito
- Jako: Satunnaistettu
- Inventiomalli: Rinnakkaistehtävä
- Naamiointi: Ei mitään (avoin tarra)
Aseet ja interventiot
Osallistujaryhmä / Arm |
Interventio / Hoito |
|---|---|
|
Active Comparator: DPP + Breastfeeding (Tx1)
Patients randomized to Tx1 will receive education in the Diabetes Prevention Program (DPP) and intensive breastfeeding education and support. Ante- and postpartum education includes access to the mHealth app and individualized 1-on-1 health coaching. Phase I is delivered antepartum and includes: four (4) 1-hour DPP-based educational sessions and six (6) 20-minute educational videos on lactation. Phase II is delivered postpartum and includes: in-hospital lactation support and two (2) 1-hour DPP-based educational sessions. Participants will continue to receive individualized 1-on-1 health coaching through 3 months postpartum. |
The intervention will be administered by professionally trained, certified health coaches. Phase I consists of four 1-hour DPP-based sessions to be completed during pregnancy. Each session will be pre-recorded and archived on a secure, private mHealth application. Participants will be asked to complete each session on their own time. A health coach will follow up weekly via phone to check on progress and will work with the participant 1-on-1, if needed. Phase I will be completed by week 36 of pregnancy. Prior to delivery, participants are invited to a virtual focus group about their experiences. Phase II consists of two 1-hour DPP-based sessions to be completed after delivery. Each session will be pre-recorded and archived on the same mHealth application. Participants will begin Phase II within 1 week of delivery with the same health coach. Phase II will be completed by week 12 postpartum. Upon completion, participants are invited to a virtual focus group about their experiences. Phase I also consists of six (6) breastfeeding videos that are pre-recorded into 15-20 minute sessions and will be available on the mHealth application. Participants will have access to the first 2 sessions by week 28 of pregnancy and need to complete the remaining 4 sessions by week 36 of pregnancy. Each session is taught by an International Board Certified Lactation Consultant (IBCLC). Participants will receive 1-on-1 lactation support by the same DPP health coach. The health coach is a professionally trained Certified Breastfeeding Specialist (CBS). She will assist participants with any questions related to lactation. If the health coach is unable to help with a specific issue, she will contact the IBCLC-of-record, who will provide assistance to the health coach only. If the health coach or IBCLC deems additional care necessary, the participant will be referred to their primary care physician. The IBCLC will not have direct contact with the study participants. Participants will receive regular prenatal care provided by their physician. At delivery, all participants will receive some type of lactation support in the hospital. |
|
Placebo Comparator: Usual Care
Usual care is described as obstetrical care that pregnant women with normal BMI receive and that is provided by their provider. There will not be any antepartum education or 1-on-1 health coaching. Postpartum education will only include usual care in-hospital lactation support. There will not be any other education nor 1-on-1 support. |
Participants will receive regular prenatal care provided by their physician. At delivery, all participants will receive some type of lactation support in the hospital. |
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Change in Weight
Aikaikkuna: At baseline and at delivery through 3 months postpartum
|
The study team measured maternal weight at baseline, at delivery, and at 3 months postpartum to allow for meaningful comparisons of weight change among study arms. |
At baseline and at delivery through 3 months postpartum
|
|
Maternal Weight
Aikaikkuna: At baseline and at delivery through 3 months postpartum
|
The study team measured maternal weight at baseline, at delivery, and at 3 months postpartum to allow for meaningful comparisons of weight change among study arms. |
At baseline and at delivery through 3 months postpartum
|
|
Duration of Breastfeeding and Supplementation
Aikaikkuna: At day 3, week 6, and 3 months postpartum.
|
The study team measured duration of breastfeeding and supplementation at day 3 postpartum and at specific timepoints through 3 months postpartum. Breastfeeding is defined as the feeding of human milk. The definition of "Exclusive Breastfeeding" is aligned with the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) and is as follows: the infant is fed only human milk and no other foods or fluids, not even water, except for oral rehydration solutions or drops/syrups of vitamins, minerals, or medicines. "Any Breastfeeding" is defined as the feeding of human milk supplemented with formula, water, etc. "Formula Only" is defined as the feeding of formula exclusively and no human milk. |
At day 3, week 6, and 3 months postpartum.
|
Toissijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Enrollment
Aikaikkuna: This will occur between day 1 of the first participant screened to the study participant being randomized to one of two study arms.
|
To assess recruitment and enrollment rates, the study team tracked the number of potential participants contacted/screened versus the number of participants who were eligible to enroll and the number of participants who consented to enroll in the study. |
This will occur between day 1 of the first participant screened to the study participant being randomized to one of two study arms.
|
|
mHealth Application Engagement
Aikaikkuna: At 3 months postpartum.
|
To assess intervention uptake, the study team tracked the number of calls engaging with the mobile health app and with the health coach. |
At 3 months postpartum.
|
|
mHealth Application Engagement (2)
Aikaikkuna: At 3 months postpartum.
|
To assess intervention uptake, the study team tracked the amount of time spent engaging with the mobile health app and with the health coach. |
At 3 months postpartum.
|
|
mHealth Application Usage
Aikaikkuna: At 3 months postpartum.
|
To assess intervention usage, the study team tracked logged tasks into the mobile health app. |
At 3 months postpartum.
|
Yhteistyökumppanit ja tutkijat
Sponsori
Tutkijat
- Päätutkija: Lisette Jacobson, PhD, MPA, MA, University of Kansas Medical Center
Opintojen ennätyspäivät
Opi tärkeimmät päivämäärät
Opiskelun aloitus (Todellinen)
Ensisijainen valmistuminen (Todellinen)
Opintojen valmistuminen (Todellinen)
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen Lähetetty (Todellinen)
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Todellinen)
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeksi vahvistettu
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Avainsanat
Muita asiaankuuluvia MeSH-ehtoja
- Endokriinisen järjestelmän sairaudet
- Ravitsemushäiriöt
- Metaboliset sairaudet
- Yliravitsemus
- Kehon paino
- Glukoosiaineenvaihduntahäiriöt
- Diabetes mellitus
- Patologiset tilat, merkit ja oireet
- Käyttäytyminen
- Ravitsemukselliset ja aineenvaihduntataudit
- Merkit ja oireet
- Ruokintakäyttäytyminen
- Ylipainoinen
- Lihavuus
- Prediabeettinen tila
- Imetys
- Lisääntymisfysiologiset ilmiöt
- Lisääntymis- ja virtsafysiologiset ilmiöt
- Synnytyksenjälkeinen aika
- imetyksen
Muut tutkimustunnusnumerot
- RKS2018350
- 3P20GM144269-02S2 (Yhdysvaltain NIH-apuraha/sopimus)
Lääke- ja laitetiedot, tutkimusasiakirjat
Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta
Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .